Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Peter Impey

- PMLiVE

Merck suspends Tredaptive worldwide

Trial demonstrates increased risk of serious adverse events

- PMLiVE

Bayer’s Barbara Jaszewski joins Lundbeck

She is appointed VP, global pricing and market access

- PMLiVE

Streaming Well video series aims to promote liver health

Digital health publisher teams up with the British Liver Trust

Increasing demand for online services from pharma

Study shows patients expect more help managing chronic conditions

European approval for Astellas’ first-in-class bladder drug Betmiga

Will compete with Pfizer's Detrol and Astellas' own Vesicare

- PMLiVE

J&J gets FDA panel backing for canagliflozin

Moves ahead of BMS/AZ’s Forxiga in race for US approval as first in new class of diabetes drug

- PMLiVE

FDA lowers recommended dose for sleeping pills

Says insomnia drugs like Ambien could impair ability to drive in morning

- PMLiVE

GSK and Theravance file COPD combo for EU approval

Filing for LAMA/LABA combination comes shortly after US submission

- PMLiVE

Will opportunity knock for eHealth in 2013?

If EC plans succeed, they will transform the way technology is used

Ischemix names David DeWahl as CEO

He joins the US biotech from private investment firm Colchester Healthcare Investments

- PMLiVE

NHS failing to promote clinical trials to patients

NIHR mystery shoppers report says 91 per cent of sites have no information in reception area

- PMLiVE

Royal National Orthopaedic Hospital NHS Trust appoints Grayling

Agency brought in as hospital plans £84m improvement programme

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links